MYC is upregulated in 78% of NSCLC cases, and MYC gene amplification is detected in approximately 8% of NSCLC cases, highlighting the significant contribution of MYC in NSCLC development [45,61]. The gene discussed is MYC; the disease is non-small cell lung carcinoma.